Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. annual report Heidelberg (euro adhoc) - Heidelberg, 29 June 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today announced its financial results for the 2009/2010 fiscal year, which ended on 31 March ...
Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Berlin, Germany, May 27, 2010 (euro adhoc) - NOXXON Pharma AG (NOXXON), a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of ...
Heidelberg (ots) - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today reports financial results for the third quarter and the first nine months of the fiscal year 2009/2010 ended December 31, 2009. Financials - Cash including marketable securities amounted to EUR16.4 million as of December 31, 2009 (EUR26.0 million Q3 2008/2009). Long term financial liabilities ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Accounting and Audits/Company Information/Financial Figures/Balance Sheet/quarterly report/6-month report Heidelberg (euro adhoc) - Heidelberg, November 10, 2009 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today ...
Key Figures 9M 2009 Revenue, EBIT and net loss significantly improved * Revenue: EUR 3.2 million in 9M 2009, up by 77% (9M 2008: EUR 1.8 million) * EBIT: EUR - 7.1 million in 9M 2009, improved by 17% (9M 2008: EUR -8.5 million) * Net loss: EUR - 7.1 million in 9M 2009, decreased by 13% (9M 2008: EUR -8.1 million) * Liquid assets: EUR 9.5 million at end of September 2009 (31/12/2008: EUR 12.1 million) ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information 19.10.2009 Heidelberg, 19 October 2009 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 22.09.2009 The Managing board of HeidelbergCement AG, with the consent of the Supervisory Board, has determined ...
First diagnostic laboratories start offering testing based on Epigenomics' Septin9 biomarker on October 1st Test is able to detect colorectal cancer in a simple blood draw Company hosts press conference at ECCO/ESMO Congress in Berlin today Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 13.09.2009 Today, the Managing Board of HeidelbergCement AG, with the consent of the Supervisory Board, has ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Spin-offs 26.06.2009 In the cartel proceedings against German cement companies the Higher Court of Düsseldorf decided about the appeal of HeidelbergCement against an administrative fine order from 2003. The fine in ...
Changes in the Board of Executive Directors Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. balance/companies/finances/professional career/shares/stock market Kassel (euro adhoc) - Kassel, 13 May 2009 K+S Aktiengesellschaft Changes in the Board of Executive Directors At a meeting ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 17.03.2009 Managing Board and Supervisory Board of HeidelbergCement AG decided today to propose to the Annual General Meeting of Shareholders, scheduled for 7 May 2009, a dividend of EUR 0.12 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Spin-offs 02.03.2009 (Erlangen, March 2, 2009) PROGEN Biotechnik GmbH, a wholly-owned subsidiary of november AG, has today concluded a contract with AXIS-SHIELD GmbH, Heidelberg, the Germany ...
Sydney (ots/PRNewswire) - Fenofibrate treatment reduces cardiovascular disease (CVD) risk (defined by total cardiovascular events: the composite of cardiovascular death, myocardial infarction, stroke, and coronary and carotid revascularization) in patients with type 2 diabetes and atherogenic dyslipidemia, that ...
Ingelheim, Germany (ots/PRNewswire) - - ESO Recommends Extended Time Window for Actilyse(R) INGELHEIM, Germany, January 30 /PRNewswire/ -- - For Healthcare Media outside the U.S.A., Canada, and Japan Based on key results from the European Cooperative Acute Stroke Study (ECASS 3), the European Stroke Organisation (ESO) now recommends that Actilyse(R) ...
Leonardo Venture GmbH & Co. KGaA
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/change of name Mannheim (euro adhoc) - A change in the name of the general partner in Leonardo Venture GmbH & Co. KGaA was entered into the German Commercial Register on 13 January 2009. ELGE Vermögensverwaltungsgesellschaft mbH is now trading as Leonardo Venture Verwaltungs GmbH. The ...
Leonardo Venture GmbH & Co. KGaA
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. formal requirements 23.12.2008 Legal and executive body representation at Leonardo Venture GmbH & Co. KGaA to be performed by ELGE Vermögensverwaltungsgesellschaft mbH until further ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Receipt of mandatory offer 14.11.2008 Ad Hoc Heidelberg, 14 November 2008 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) has been informed today that dievini Hopp ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.10.2008 HeidelbergCement AG ISIN DE0002966850/ WKN 296685 - HC Finance B.V. 4 ¾ % EUR 300m 9 April 2009 ISIN XS0342136313/ WKN A0TP7J HC Finance B.V. 6 3/8% EUR 1bn 25 January 2012 ISIN DE000A0TKUU3/ WKN A0TKUU HC Finance B.V. 5 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 15.10.2008 SYGNIS Pharma AG Approves Capital Increase Heidelberg, October 15, 2008 - Today the Management Board of the Heidelberg biotechnology company SYGNIS Pharma AG (Frankfurt: LIO; ISIN ...
Leonardo Venture GmbH & Co. KGaA
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. C.E.O. Interviews 01.10.2008 The Supervisory Board of Leonardo Venture GmbH & Co. KGaA and the general partner, Leonardo Venture Capital GmbH, have agreed that Leonardo Venture Capital GmbH ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan - Favourable Safety and Efficacy Profile of Actilyse(R) Confirmed by ECASS 3 Study Investigating Treatment in an Extended Time Window up to 4.5 Hours After Symptom Onset First results from ECASS 3 ...
Basel, Switzerland (ots/PRNewswire) - - Final Analysis of Study Confirms Benefit of Avastin(R) for Patients With Lung Cancer BASEL, Switzerland, September 15 /PRNewswire/ -- The final analysis of the Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown that not only did the drug significantly slow down the disease progression, it ...
LONDON and CAMBRIDGE, England and PHILADELPHIA and HEIDELBERG, Germany, September 10 (ots/PRNewswire) -- - Kinobeads(TM) Technology to Identify a New Generation of Drug Candidates for Inflammatory Diseases Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases. ...
Integration of National Starch businesses progressing on fast track ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/Geitner, Adhesives, Henkel Düsseldorf (euro adhoc) - Thomas Geitner (53), who has been a member of the Henkel Management Board since March 1, 2008, will assume responsibility for the Adhesives Technologies business ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 14.02.2008 Following its resolution of 16 January 2008, the Managing Board of HeidelbergCement AG has resolved, with the approval of the Supervisory Board, the following terms to implement a ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 16.01.2008 The Managing Board of HeidelbergCement AG has resolved, subject to the consent of the Supervisory Board, to make use of the authorised capital and to implement a cash capital ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 20.11.2007 Erlangen, 20. November 2007. According to the decision made at the last annual shareholder´s meeting on May 22nd 2007, november AG has successfully completed the capital increase ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.10.2007 Stuttgart, 12 October 2007. Over the coming years, ALTA FIDES AG, Stuttgart will grow more strongly than planned so far. This growth is based on the newly established company of ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 13.09.2007 One of the key issues in the integration of Hanson´s treasury into the centralised Group Treasury of HeidelbergCement was realized shortly after the change of control on 23 August ...